Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases

Clinical trial NCT00807170 · TERMINATED

Trial details

NCT number: NCT00807170
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2009-05-01
Primary completion: 2010-08-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.